Mark Chen
If you’ve been doing keto for a while, or you’re thinking about starting, a headline like this one probably stopped you cold. A study published in Nature on July 15, 2026 by researchers at MIT found that a ketogenic diet accelerated tumor growth in the small intestine in mice, sometimes matching or even exceeding rates seen in mice eating an obesogenic high-fat, high-calorie diet. That’s a striking finding. And it deserves a straight explanation rather than either panic or dismissal.
Here’s what makes this study genuinely worth paying attention to: it came from Omer Yilmaz, director of the MIT Stem Cell Initiative and a Koch Institute member, and his team. This isn’t fringe science. It’s peer-reviewed, published in one of the most scrutinized journals in the world, and it complicates a story that the keto community has been telling fairly confidently for years, which is that low-carb eating is broadly protective against cancer. According to MIT News, the same diet that promoted small intestinal tumors actually suppressed colon tumor development in the same animals. One diet. Two organs. Opposite effects.
That contradiction is the part I want to sit with, because I think it’s the part that matters most for anyone currently on keto or considering it.
- MIT's July 2026 Nature study found keto accelerated small intestine tumors in mice, even in lean animals.
- The same keto diet suppressed colon tumors, showing opposite effects in two GI organs.
- Tumor growth was driven by fat metabolism and stem cell proliferation, not by ketone bodies like BHB.
- People with familial adenomatous polyposis (FAP) or small intestine cancer history face the most clinically relevant risk.
- These are mouse findings , human research is needed before drawing firm personal conclusions.
What the Researchers Actually Found
The mechanism here is specific and worth understanding, because it’s not what most people assume. The culprit wasn’t ketones. Ketone bodies like beta-hydroxybutyrate (BHB), which keto advocates often credit with anti-inflammatory and potentially anti-cancer effects, were described by the MIT team as “metabolic bystanders” in this context. They weren’t driving the tumor growth.
What was driving it: the way intestinal cells burn dietary fat directly for energy. That process of fat metabolism triggered rapid proliferation of intestinal stem cells in the small intestine. More stem cell activity means more cellular division. More cellular division means more opportunities for something to go wrong, for a mutation to slip through and become uncontrolled growth.
This is a biologically plausible mechanism, not a statistical quirk. And it’s site-specific, which is the part that upends the simpler narrative. The colon and the small intestine don’t behave the same way metabolically. What suppresses tumor risk in one location can, apparently, accelerate it in another. As Yilmaz put it directly: “What might be beneficial for one tissue may be detrimental for another tissue.”
Why the Small Intestine Specifically
Small intestinal cancer is less common than colon cancer, but it’s been rising. That rise has been documented over recent decades, and clinicians don’t have a fully satisfying explanation for it. One group at particularly high risk: people with inherited conditions like familial adenomatous polyposis, or FAP. FAP causes the development of numerous polyps throughout the GI tract, including the small intestine, and significantly elevates cancer risk.
If you or a family member has FAP or another hereditary GI cancer syndrome, this study is the one that should prompt a direct conversation with your gastroenterologist or oncologist before continuing or starting a ketogenic diet. That’s not a hedge. It’s specific and it’s warranted based on what the MIT team found, as covered by both EurekAlert and News-Medical on July 15, 2026.
For the general population without these inherited conditions, the picture is less clear and less alarming, but it’s still genuinely uncertain territory now.
The Colon vs. Small Intestine Paradox
A table helps here, because the contrast between the two findings in this single study is exactly the kind of thing that gets lost when people summarize research in a sentence.
| Location | Effect of Ketogenic Diet on Tumors | Mechanism Identified |
|---|---|---|
| Small intestine | Accelerated tumor growth (equal to or exceeding obesogenic diet) | Fat metabolism drives stem cell proliferation |
| Colon | Suppressed tumor development | Different metabolic environment; colon cells respond differently |
This side-by-side is why blanket statements about keto and cancer risk, in either direction, are now harder to make with confidence. The diet isn’t uniformly protective against GI cancers. It’s also not uniformly harmful. It depends on where in the gut you’re looking and, likely, on factors researchers are still working to characterize.
What This Means If You’re Currently Doing Keto
You might be wondering whether you should stop. Here’s what I tell people in situations like this: one mouse study, however well-designed, doesn’t override years of other evidence or your personal health context. Mouse models don’t always translate to humans. Dietary studies in animals control variables we can’t control in real life. These are real limitations.
What this study does, though, is add a legitimate reason to hold the pro-keto-for-cancer-prevention argument more lightly than some advocates have. The claim that keto is broadly protective against cancer was always more confident than the evidence fully supported. This narrows it further.
A few practical considerations, not prescriptions:
If you’re doing keto for weight loss, metabolic health, or blood sugar control, and you don’t have elevated GI cancer risk, this study doesn’t give you a strong reason to stop today. Continue monitoring the research as it develops, and talk to your doctor at your next visit.
If you’re doing keto partly because you believe it’s protective against cancer, it’s worth being honest that the picture is more complicated now than it was two weeks ago.
If you have FAP, Lynch syndrome, or a personal or family history of small intestine cancer or polyps, please bring this study to your specialist before continuing. That’s the population where the clinical relevance is highest right now.
The science here is genuinely new. Human trials haven’t been done yet, and this research will almost certainly prompt them. I’d keep watching what comes out of Yilmaz’s lab and others working in this space over the next year or two. This finding is too specific and too mechanistically grounded to ignore, but it’s also too early to treat as a final verdict on a diet that millions of people are using for legitimate health reasons. Stay curious, stay skeptical of anyone who tells you this is simple, and loop in your healthcare team.
Sources
- Ketogenic diets may increase cancer risk in the small intestine (July 15, 2026)
- Ketogenic diets may increase cancer risk in the small intestine (July 15, 2026)
- Ketogenic diet may increase small intestine cancer risk in mice (July 15, 2026)
- Could The Keto Diet Be Fueling Cancer? New Study Challenges Popular Theory (July 15, 2026)
Photo: Edward Jenner via Pexels
This article is for general informational purposes only and does not constitute medical or dietary advice. Always consult a licensed healthcare provider or registered dietitian before making significant changes to your diet, especially if you have a medical condition.
